
16/07/2025
Nippon Shinyaku, Boston Children’s to partner on rare disease research
Nippon Shinyaku Pharma will partner with Boston Children’s Hospital to study and develop treatments for rare diseases like AADC deficiency.
We are dedicated to sharing the latest news, research, and patient perspectives from the AADC community.
Be the first to know and let us send you an email when AADC News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Want your business to be the top-listed Media Company?